# To Evaluate the Efficacy and Safety of ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defects Caused by Neurotrophic Keratitis

> **NCT07120308** · PHASE2 · COMPLETED · sponsor: **Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.** · enrollment: 28 (actual)

## Conditions studied

- Corneal Epithelial Defect

## Interventions

- **DRUG:** ZKY001 eye drops
- **DRUG:** Vehicle (placebo)

## Key facts

- **NCT ID:** NCT07120308
- **Lead sponsor:** Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-15
- **Primary completion:** 2023-01-30
- **Final completion:** 2023-01-30
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2025-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07120308

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07120308, "To Evaluate the Efficacy and Safety of ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defects Caused by Neurotrophic Keratitis". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07120308. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*